Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

NCT01646489 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
Chronic Hepatitis C

Interventions

DRUG: Miravirsen sodium
DRUG: Telaprevir

Sponsor

Santaris Pharma A/S